| 8:50 | Opening of Symposium: Prof. Trevor Hambley (Dean of Science) |
| 9:00 | Plenary presentation: Prof. Annette Beck-Sickinger (Universität Leipzig) Semi-synthesis of proteins to expand biological function |
| 9:40 | Session 1 (studying macromolecules). Session chair: A/Prof. Richard Payne |
| Joel Mackay - Integrative structural analysis of a 1-MDa chromatin remodeling complex | |
| Rob Thompson - Probing the effects of post-translational modifications on the activity of tick-derived anticoagulants | |
| Sandro Ataide - The Signal Recognition Particle RNA and its multi functions | |
| Jacqui Matthews - Protein Engineering and Transcriptional Regulation | |
| 11:00 | Morning tea |
| 11:30 | Session 2 (enabling technologies on campus). Session chair: Prof. Kate Jolliffe |
| Ann Kwan - SMB NMR Facility and chemical biology | |
| Adrian Smith - The Advanced Cytometry Facility - enabling technologies for single cell analysis | |
| Pam Young - Cellular Imaging Facility in the Charles Perkins Centre: A Node of Sydney Microscopy and Microanalysis | |
| Ben Crossett - What is the MSCF? | |
| 12:00 | 3-Minute poster presentations. Session chair: Prof. Kate Jolliffe |
| 12:50 | Lunch and poster session |
| 14:00 | Session 3 (targeting and imaging). Session chair: A/Prof. Renae Ryan |
| Margie Sunde - Using amyloid to your advantage - functional fibrils from fungal hydrophobin proteins | |
| Peter Rutledge - Visualising ion flux with small molecule probes, and nanoparticles | |
| Andrew Katsifis - TBD | |
| Phil Robinson - TBD | |
| Liz New - Molecular imaging tools for intracellular redox state and biological metal ions | |
| 15:40 | Afternoon tea and poster session |
| 16:00 | Session 4 (developing active small molecules). Session chair: Dr Benjamin Parker |
| Mary Collins - Multiple binding interfaces on nACh receptors allude to stoichiometric dependent actions of antagonists | |
| Rachel Codd - New siderophore scaffolds from precursor-directed biosynthesis | |
| Paul Witting - Pre-treatment with the synthetic antioxidant T-butyl bisphenol protects cerebral tissues from experimental ischemia reperfusion injury | |
| Lenka Munoz - Development of allosteric MK2 inhibitors with blood-brain barrier permeability | |
| 17:20 | Plenary presentation: Dr James Crawford (Genentech) Potent and Selective Pyridone BTK Inhibitors With Activity Against Mutant Forms of BTK |
| 18:00 | Closing remarks Drinks reception (Law Foyer) |